bioAffinity's technology platform is successfully used with its commercial test, CyPath® Lung, a noninvasive diagnostic test for lung cancer that has demonstrated high sensitivity and specificity for ...
Swedish scientists have developed a new device that can detect tuberculosis (TB) DNA in exhaled air, offering a potential alternative when ...
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
SAN ANTONIO, February 25, 2026--bioAffinity Technologies announced validation study with BAMC to assess deep suction sputum samples for lung cancer detection with CyPath Lung.
AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...
Background Treatment failure remains a major challenge in tuberculosis (TB) management. Rapid and objective assessment of treatment response is essential, as existing tools have limited accuracy and ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Between Nov 19 and Dec 3, 2020, 114 clinics were screened, of which 29 were randomly assigned and ...
A gloved hand holds a test strip in a small plastic vial, with two horizontal red lines on it The tuberculosis test strips developed by Tulane University’s Zhen Huang indicate the presence or absence ...
NEW YORK – Researchers from Princeton University have developed a CRISPR-based assay for tuberculosis detection that requires few resources and could be used in settings without significant laboratory ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Tuberculosis rates rose by 4·6% from 2020 to 2023, possibly due to patient dropouts at the diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results